| 1 | CXCL10, CXCR3, KLF2
|
| The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells.
|
| Preston GC, Feijoo-Carnero C, Schurch N, Cowling VH, Cantrell DA.
|
| PLoS One 8(10):e77537. doi: 10.1371/journal.pone.0077537. eCollection 2013.
2013
|
| 2 | CXCR3
|
| CXCR3 in T cell function.
|
| Groom JR, Luster AD.
|
| Exp Cell Res 317(5):620-31.
2011
|
| 3 | CXCR3
|
| CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.
|
| Winkler AE, Brotman JJ, Pittman ME, Judd NP, Lewis JS Jr, Schreiber RD, Uppaluri R.
|
| Cancer Res 71(17):5707-16. Epub 2011 Jul 6.
2011
|
| 4 | CXCL9, CXCR3
|
| Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.
|
| Schroepf S, Kappler R, Brand S, Prell C, Lohse P, Glas J, Hoster E, Helmbrecht J, Ballauff A, Berger M, von Schweinitz D, Koletzko S, Lacher M.
|
| Inflamm Bowel Dis nflamm Bowel Dis. 2010 Apr 30. [Epub ahead of print]PMID: 20848514 2010
|
| 5 | CXCL10, CXCL11, CXCL9, CXCR3
|
| Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
|
| Trotta T, Costantini S, Colonna G.
|
| Mol Immunol 47(2-3):332-9. Epub 2009 Oct 1.PMID: 19800124 2009
|
| 6 | CXCL9, CXCR3
|
| Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
|
| Wasmuth HE, Lammert F, Zaldivar MM, Weiskirchen R, Hellerbrand C, Scholten D, Berres ML, Zimmermann H, Streetz KL, Tacke F, Hillebrandt S, Schmitz P, Keppeler H, Berg T, Dahl E, Gassler N, Friedman SL, Trautwein C.
|
| Gastroenterology 137(1):309-19, 319.e1-3. Epub 2009 Apr 1.PMID: 19344719 2009
|
| 7 | CXCR3
|
| A common intronic variant of CXCR3 is functionally associated with gene expression levels and the polymorphic immune cell responses to stimuli.
|
| Choi JW, Park CS, Hwang M, Nam HY, Chang HS, Park SG, Han BG, Kimm K, Kim HL, Oh B, Kim Y.
|
| J Allergy Clin Immunol 122(6):1119-1126.e7. Epub 2008 Oct 28.
2008
|
| 8 | CXCR3
|
| Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.
|
| Datta D, Contreras AG, Grimm M, Waaga-Gasser AM, Briscoe DM, Pal S.
|
| J Am Soc Nephrol 19(12):2437-46. Epub 2008 Oct 2.
2008
|
| 9 | CXCL11, CXCR3
|
| ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair.
|
| Yates CC, Whaley D, Y-Chen A, Kulesekaran P, Hebda PA, Wells A.
|
| Am J Pathol 173(3):643-52. Epub 2008 Jul 31.
2008
|
| 10 | CXCL11, CXCR3
|
| Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
|
| Cox JH, Dean RA, Roberts CR, Overall CM.
|
| J Biol Chem 283(28):19389-99. Epub 2008 Apr 14.
2008
|
| 11 | IL17F, CXCR3
|
| The IL-17F signaling pathway is involved in the induction of IFN-gamma-inducible protein 10 in bronchial epithelial cells.
|
| Kawaguchi M, Kokubu F, Huang SK, Homma T, Odaka M, Watanabe S, Suzuki S, Ieki K, Matsukura S, Kurokawa M, Adachi M.
|
| J Allergy Clin Immunol 119(6):1408-14. Epub 2007 Apr 5. 2007
|
| 12 | CXCR3
|
| Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes.
|
| Kawada K, Hosogi H, Sonoshita M, Sakashita H, Manabe T, Shimahara Y, Sakai Y, Takabayashi A, Oshima M, Taketo MM.
|
| Oncogene 26(32):4679-88. Epub 2007 Feb 5.
2007
|
| 13 | CXCR3
|
| CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
|
| Colvin RA, Campanella GS, Manice LA, Luster AD.
|
| Mol Cell Biol 26(15):5838-49. 2006
|
| 14 | CXCL11, CXCR3
|
| The expression and possible roles of chemokine CXCL11 and its receptor CXCR3 in the human endometrium.
|
| Hirota Y, Osuga Y, Koga K, Yoshino O, Hirata T, Morimoto C, Harada M, Takemura Y, Nose E, Yano T, Tsutsumi O, Taketani Y.
|
| J Immunol 177(12):8813-21.
2006
|
| 15 | CXCL11, CXCR3
|
| Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.
|
| Dagan-Berger M, Feniger-Barish R, Avniel S, Wald H, Galun E, Grabovsky V, Alon R, Nagler A, Ben-Baruch A, Peled A.
|
| Blood 107(10):3821-31. Epub 2005 Dec 20.
2006
|
| 16 | CXCR3, CXCR5, RBP3, SAG
|
| Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate.
|
| Howard OM, Dong HF, Su SB, Caspi RR, Chen X, Plotz P, Oppenheim JJ.
|
| Blood 105(11):4207-14. Epub 2005 Feb 15. 2005
|
| 17 | CXCR3,CXCR4
|
| Clinical significance of CXCR3 and CXCR4 expression in primary melanoma.
|
| Longo-Imedio MI, Longo N, Trevino I, Lazaro P, Sanchez-Mateos P.
|
| Int J Cancer 117(5):861-5. 2005
|
| 18 | CXCL11, CXCR3
|
| Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping.
|
| Ehlert JE, Addison CA, Burdick MD, Kunkel SL, Strieter RM.
|
| J Immunol 173(10):6234-40.
2004
|
| 19 | CXCR3, CXCl9, CXCL10, CXCL11
|
| Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
|
| Xanthou G, Williams TJ, Pease JE.
|
| Eur J Immunol 33(10):2927-36. 2003
|
| 20 | CXCL10, CXCR3
|
| Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
|
| Tensen CP, et al.
|
| J Invest Dermatol 112(5):716-22. 1999
|
| 21 | CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, CCR8, CCR9, CX3CR1, CXCR1, CXCR2, CXCR3, CXCR4, XCR1
|
| Intracellular signalling pathways induced by chemokines in natural killer cells.
|
| Maghazachi AA.
|
| Cell Signal 11(6):385-90. Review 1999
|
| 22 | ABCC11, ABCC6P1, ABCC6P2, ACYP2, APOB48R, CCL22, CCP110, CDC37, CIAPIN1, CLN3, COQ9, CX3CL1, CXCR3, DDX28, DHX38, DOK4, EARS2, EARS2, EIF3CL, GDE1, GTF3C1, LKAP, MAZ, NOMO1, NOMO2, NPIPA1, NUPR1, ORIPL, PMFBP1, RBKH, SLC7A5P1, TCCK, UBFD1, XPO6, ZG16, ZP2
|
| Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q.
|
| Loftus BJ, Kim UJ, Sneddon VP, Kalush F, Brandon R, Fuhrmann J, Mason T,Crosby ML, Barnstead M, Cronin L, Deslattes Mays A, Cao Y, Xu RX, Kang HL,Mitchell S, Eichler EE, Harris PC, Venter JC, Adams MD.
|
| Genomics 60(3):295-308. 1999
|
| 23 | CXCR3
|
| Lymphocyte-specific chemokine receptor CXCR3 : regulation, chemokine binding and gene localization.
|
| Loetscher M, Loetscher P, Brass N, Meese E, Moser B.
|
| Eur J Immunol 28 : 3696-3705. 1998
|
| 24 | CXCR3
|
| Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors.
|
| Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL, Gould SL, Springer MS, DeMartino JA.
|
| J Biol Chem 273 : 18288-18291. 1998
|
| 25 | CXCR3
|
| The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.
|
| Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark-Lewis I, Moser B.
|
| Eur J Immunol 28 : 961-972. 1998
|
| 26 | MLNR, CXCR3, PFKM
|
| Physical and genetic mapping of the muscle phosphofructokinase gene (PFKM) : reassignment to human chromosome 12q.
|
| Howard TD, et al.
|
| Genomics 34 : 122-127. 1996
|
| 27 | CXCR3, PRLHR, GPR10L, UTS2R
|
| Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors.
|
| Marchese A, et al.
|
| Genomics 29 : 335-344. 1995
|